Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: final results of a noninterventional study

BACKGROUND: Data are limited regarding routine use of everolimus after initial vascular endothelial growth factor (VEGF)–targeted therapy. The aim of this prospective, noninterventional, observational study was to assess efficacy and safety of everolimus after initial VEGF-targeted treatment in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmann, Lothar, Kube, Ulrich, Doehn, Christian, Steiner, Thomas, Goebell, Peter J, Kindler, Manfred, Herrmann, Edwin, Janssen, Jan, Weikert, Steffen, Scheffler, Michael T, Schmitz, Joerg, Albrecht, Michael, Staehler, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413536/
https://www.ncbi.nlm.nih.gov/pubmed/25925846
http://dx.doi.org/10.1186/s12885-015-1309-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413536/
https://www.ncbi.nlm.nih.gov/pubmed/25925846
http://dx.doi.org/10.1186/s12885-015-1309-7

Ejemplares similares